Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer

J Natl Cancer Inst. 2018 Jul 1;110(7):696-698. doi: 10.1093/jnci/djy014.

Steffi Oesterreich^{1

2}, Peter C Lucas^{3

4}, Priscilla F McAuliffe⁵, Tullia C Bruno^{6

7}, Dario A A Vignali⁷

¹ Department of Pharmacology and Chemical Biology, Womens Cancer Research Center, UPMC Hillman Cancer Center, Magee Womens Research Institute, University of Pittsburgh, Pittsburgh, PA.
² Section of Breast Surgery, Division of Surgical Oncology, Womens Cancer Research Center, UPMC Hillman Cancer Center, Magee Womens Research Institute, University of Pittsburgh, Pittsburgh, PA.
³ Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
⁴ NSABP/NRG Oncology, Pittsburgh, PA.
⁵ Department of Surgery, Womens Cancer Research Center, UPMC Hillman Cancer Center, Magee Womens Research Institute, University of Pittsburgh, Pittsburgh, PA.
⁶ Department of Immunology (TCB, DAAV), University of Pittsburgh School of Medicine, Pittsburgh, PA.
⁷ Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA.

No abstract available

Publication types